Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Revenue: 2018-2024

Historic Revenue for Burning Rock Biotech (BNR) over the last 7 years, with Dec 2024 value amounting to $70.7 million.

  • Burning Rock Biotech's Revenue fell 8.74% to -$223.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $187.9 million, marking a year-over-year increase of 165.91%. This contributed to the annual value of $70.7 million for FY2024, which is 6.64% down from last year.
  • Burning Rock Biotech's Revenue amounted to $70.7 million in FY2024, which was down 6.64% from $75.7 million recorded in FY2023.
  • Over the past 5 years, Burning Rock Biotech's Revenue peaked at $81.7 million during FY2022, and registered a low of $65.9 million during FY2020.
  • Moreover, its 3-year median value for Revenue was $75.7 million (2023), whereas its average is $76.0 million.
  • As far as peak fluctuations go, Burning Rock Biotech's Revenue grew by 20.96% in 2021, and later fell by 7.31% in 2023.
  • Burning Rock Biotech's Revenue (Yearly) stood at $65.9 million in 2020, then increased by 20.96% to $79.7 million in 2021, then increased by 2.47% to $81.7 million in 2022, then dropped by 7.31% to $75.7 million in 2023, then dropped by 6.64% to $70.7 million in 2024.